P
Pharmedic Pharmaceutical Medicinal JSC
VN:PMC
Pharmedic Pharmaceutical Medicinal JSC
VN:PMC
Price:
140 000
VND
-2.03%
Market Cap:
₫1.3T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Pharmedic Pharmaceutical Medicinal JSC
VN:PMC
|
VN |
|
A
|
Asia Biomass PCL
SET:ABM
|
TH |
|
CareerIndex Inc
TSE:6538
|
JP |
|
G
|
Green Energy Group Ltd
HKEX:979
|
HK |
|
Pharmaust Ltd
ASX:PAA
|
AU |
|
M
|
MINISO Group Holding Ltd
HKEX:9896
|
CN |
|
ECN Capital Corp
TSX:ECN
|
CA |
|
LaSalle Logiport REIT
TSE:3466
|
JP |
|
clearvise AG
XETRA:ABO
|
DE |
|
Peab AB
STO:PEAB B
|
SE |
|
Bakkt Holdings Inc
NYSE:BKKT
|
US |
|
C
|
China Southern Power Grid Technology Co Ltd
SSE:688248
|
CN |
|
S
|
Sea Harvest Group Ltd
JSE:SHG
|
ZA |
|
Xcel Brands Inc
NASDAQ:XELB
|
US |
|
F
|
Forehope Electronic Ningbo Co Ltd
SSE:688362
|
CN |
Relative Value
The Relative Value of one PMC stock under the Base Case scenario is hidden VND. Compared to the current market price of 140 000 VND, Pharmedic Pharmaceutical Medicinal JSC is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PMC Relative Value
HIDDEN
Multiples Across Competitors
PMC Competitors Multiples
Pharmedic Pharmaceutical Medicinal JSC Competitors
Pharmedic Pharmaceutical Medicinal JSC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| VN |
P
|
Pharmedic Pharmaceutical Medicinal JSC
VN:PMC
|
1.3T VND | 2.4 | 15.9 | 11.5 | 12.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 4.9 | 28.3 | 15.7 | 22.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.2B CHF | 5.1 | 20.4 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
